Literature DB >> 23964073

Do reduction and healing of the bony fragment really matter in arthroscopic bony Bankart reconstruction?: a prospective study with clinical and computed tomography evaluations.

Chun-Yan Jiang1, Yi-Ming Zhu, Xin Liu, Feng-Long Li, Yi Lu, Guan Wu.   

Abstract

BACKGROUND: Bony Bankart lesions can be treated with arthroscopic repair. However, few studies have evaluated the importance of bony fragment reduction and healing to stability of the glenohumeral joint after arthroscopic bony Bankart repair.
PURPOSE: To evaluate functional results after surgery and determine the correlation between reduction and healing of the fracture and postoperative stability of the glenohumeral joint. STUDY
DESIGN: Case series; Level of evidence, 4.
METHODS: A total of 50 patients (47 men, 3 women; average age, 27.6 years; range, 16.5-50.1 years) with bony Bankart lesions and recurrent anterior shoulder dislocations were treated with arthroscopic reduction and internal fixation with suture anchors. The average follow-up period was 32.5 months (range, 24.3-61.2 months). Preoperative and postoperative range of motion and American Shoulder and Elbow Surgeons (ASES), Constant-Murley, and Rowe scores were compared to evaluate the results of the surgeries. Sequential 3-dimensional computed tomography (CT) scans were available for 37 patients and were analyzed to investigate the effect of the bony defect of the glenoid and the correlation between the success of the surgery and reduction and healing of the bony fragment.
RESULTS: After surgery, active forward elevation was significantly improved (P < .05). No significant differences were found regarding external and internal rotations after surgery. The ASES, Constant-Murley, and Rowe scores improved significantly after surgery. Redislocations occurred in 3 patients, and a positive anterior apprehension sign was detected in 1 patient during follow-up. The overall failure rate was 8.0% (4/50). The CT scans during the follow-up period showed a nonunion of the bony fragment in 13.5% of cases (5/37). The reconstructed size of the glenoid was <80% in 3 of the 4 failure cases but >80% in all of the successful cases.
CONCLUSION: Arthroscopic reduction and fixation of a bony Bankart lesion can achieve good results in selected cases. The size of the reconstructed glenoid is crucial to the success of the surgery.

Entities:  

Keywords:  Bankart lesion; arthroscopic surgery; fracture; shoulder instability; suture anchor

Mesh:

Year:  2013        PMID: 23964073     DOI: 10.1177/0363546513499304

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  6 in total

1.  Arthroscopic repair of glenoid rim fractures: a ligamentotaxis surgical technique.

Authors:  A Corradini; G Campochiaro; M Gialdini; M Rebuzzi; P Baudi
Journal:  Musculoskelet Surg       Date:  2018-10-20

Review 2.  Arthroscopic Bankart Repair for the Management of Anterior Shoulder Instability: Indications and Outcomes.

Authors:  Steven DeFroda; Steven Bokshan; Evan Stern; Kayleigh Sullivan; Brett D Owens
Journal:  Curr Rev Musculoskelet Med       Date:  2017-12

3.  When to Abandon the Arthroscopic Bankart Repair: A Systematic Review.

Authors:  Benjamin J Levy; Nathan L Grimm; Robert A Arciero
Journal:  Sports Health       Date:  2020-07-27       Impact factor: 3.843

4.  Mean Glenoid Defect Size and Location Associated With Anterior Shoulder Instability: A Systematic Review.

Authors:  Lionel J Gottschalk; Aaron J Bois; Marcus A Shelby; Anthony Miniaci; Morgan H Jones
Journal:  Orthop J Sports Med       Date:  2017-01-05

5.  Arthroscopy Limits on Anterior Shoulder Instability.

Authors:  Jair Simmer Filho; Raul Meyer Kautsky
Journal:  Rev Bras Ortop (Sao Paulo)       Date:  2021-10-25

6.  Enlargement of Glenoid Defects in Traumatic Anterior Shoulder Instability: Influence of the Number of Recurrences and Type of Sport.

Authors:  Shigeto Nakagawa; Ritsuro Ozaki; Yasuhiro Take; Naoko Mizuno; Tatsuo Mae
Journal:  Orthop J Sports Med       Date:  2014-04-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.